Investigational Personalized mRNA Cancer Vaccine Gains Breakthrough Therapy Designation from FDA February 28, 2023 AutoBot News 0 Moderna and Merck’s investigational personalized mRNA cancer vaccine has been granted Breakthrough Therapy Designation by FDA.
